Efficacy and safety of "sandwich" therapy (initial Interferon induction with end-treatment Interferon boost) with Rebetron in the treatment of naive patients with chronic hepatitis C.

被引：0
|
作者：
Bassan, I [1 ]
Bloom, ML [1 ]
Phillips, RS [1 ]
Muirhead, S [1 ]
Garrison, S [1 ]
机构：
[1] Pharma Res Grp Inc, Miami Beach, FL USA
来源：
HEPATOLOGY | 2001年 / 34卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
1699
引用
收藏
页码：597A / 597A
页数：1
相关论文
共 50 条
  • [1] Efficacy of Rebetron (interferon and ribavirin) comparison therapy in the treatment of patients with interferon-refractory or interferon-relapsed chronic hepatitis C.
    Nelson, JB
    HEPATOLOGY, 2000, 32 (04) : 553A - 553A
  • [2] A comparison of standard and induction interferon therapy with and without initial ribavirin in treatment naive patients with chronic hepatitis C.
    Peine, CJ
    Albrecht, JK
    Roel, JP
    Gundersen, BA
    Kirchner, JP
    Zins, B
    McKee, D
    Ho, SB
    Smith, T
    HEPATOLOGY, 2000, 32 (04) : 364A - 364A
  • [3] Efficacy of Rebetron (interferon and ribavirin) combination therapy in the treatment of patients with chronic hepatitis C not previously treated with interferon.
    Nelson, JB
    HEPATOLOGY, 2000, 32 (04) : 553A - 553A
  • [4] Induction therapy with consensus interferon in the treatment of patients with chronic hepatitis C.
    Kwo, PY
    Fields, S
    Chalasani, N
    Cho, W
    Crabb, DW
    Cummings, OW
    Imperiale, TF
    Lumeng, L
    McGill, JM
    Ness, RM
    Pintozzi, R
    Jones, B
    Lansford, C
    Maier, J
    Isenberg, M
    Mark, D
    Bennet, C
    Noar, M
    McCone, J
    Chasen, R
    Geissinger, B
    Goldstein, M
    Thuluvath, P
    GASTROENTEROLOGY, 2000, 118 (04) : A1460 - A1460
  • [5] High dose induction therapy with consensus interferon and ribavirin for treatment-naive patients with hepatitis C.
    Kaiser, S
    Hass, H
    Gregor, M
    HEPATOLOGY, 2002, 36 (04) : 362A - 362A
  • [6] High dose induction therapy with alpha interferon for treatment of chronic hepatitis C.
    Menon, KVN
    Forrest, EH
    Neilson, M
    MacSween, RNM
    Morris, AJ
    GASTROENTEROLOGY, 1999, 116 (04) : A1246 - A1246
  • [7] High dose induction therapy with consensus interferon followed by combination therapy with ribavirin for treatment-naive patients with chronic hepatitis C.
    Kaiser, S
    Kreysel, C
    Gregor, M
    HEPATOLOGY, 2000, 32 (04) : 561A - 561A
  • [8] Efficacy and tolerability of interferon (Intron A®) plus Ribavirin (Rebetron®) administered daily for two months.: Then thrice weekly interferon (Intron A®) plus Ribavirin (Rebetron®), versus standard thrice weekly administration of Rebetron for the treatment of chronic hepatitis C in patients naive to interferon therapy
    Epstein, MS
    King, CE
    Ravendhran, N
    Finkel, RG
    Lobis, IF
    Laurin, J
    Korman, LY
    Axelrad, AM
    Snow, ND
    Praschak, PM
    HEPATOLOGY, 2000, 32 (04) : 552A - 552A
  • [9] Influence of HLA haplotypes on the efficacy of interferon treatment in patients with chronic hepatitis C.
    Oshita, M
    Kuzushita, N
    Hiramatsu, N
    Ohkawa, K
    Mochizuki, K
    Kanto, T
    Mita, E
    Kubo, M
    Asai, A
    Tanimura, H
    Abe, T
    Enomoto, N
    Fujimoto, K
    Hosui, A
    Sato, A
    Okada, N
    Naniyo, A
    Miyatake, H
    Sasaki, Y
    Kasahara, A
    Masuzawa, M
    Hayashi, N
    HEPATOLOGY, 1998, 28 (04) : 475A - 475A
  • [10] Efficacy of daily interferon-alpha in combination with ribavirin in the treatment of naive patients MQTH chronic hepatitis C.
    Urbanek, P
    HEPATOLOGY, 2002, 36 (04) : 578A - 578A
12345